what kind of bad joke
$Vir Biotechnology(VIR.US$ Just bought more. and wait for further dump to buy. Seriously, wall street are upset to Vir’s attitude, not science not finance.
This stupid trial is paid by GSK, HHS, BARDA. Let me make it frank, antibody to virus is proved to be low effectiveness and expensive, you have seen that in Covid. Regeneron faced the same issue for many years, unless trial design is tricky. There is an example antibody works as miracle cure. Regn Cov gives 1200mg antibody per dose already a lot. Trump received 8000mg antibody, so Trump is good pretty soon. That’s how you shoul design experiment…
now stock price is even lower than cash and cash equivalent net of liability the companys has. Unbelievably cheap.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
搞经济 抄底 加仓 : Agreed. if this fail drop 40% . $Pfizer (PFE.US)$ should be negative -40% by now
rational Duck_7524 : does that mean it take 6 or month to have positive news or blessing for gov approval?
QianmengYuOP 搞经济 抄底 加仓: Using antibodies to fight the virus is all about wearing clothes to bathe, which is useful but can't be washed clean... REGN is no different. Because a large percentage of other people's antibodies are destroyed by the immune system. Not at all the same time as the movie's needle. Buy it slowly. The vir antibody platform isn't particularly powerful. It's normal for it to fail. Every time it's made a fortune like sotrovimab, and the stock price is in three digits. What's more, the most promising one is actually the siRNA pipeline.
QianmengYuOP rational Duck_7524: To get approval, they need phase 3 with excellent result, or phase 3 good + phase 4 OK. In common sense, this PENINSULA project is dead. Unless VIR could find some great point, and GSK wants to pay for phase 3. However, this peninsula is pretty a side bonus project that is mainly sponsored by third party.